| Autor: |
Urlić I; Department of Oncology and Radiotherapy, University Hospital of Split, 21000 Split, Croatia., Šoljić V; Laboratory of Morphology, Department of Histology and Embryology, School of Medicine, University of Mostar, 88000 Mostar, Bosnia and Herzegovina.; Faculty of Health Studies, University of Mostar, 88000 Mostar, Bosnia and Herzegovina., Vukoja M; Laboratory of Morphology, Department of Histology and Embryology, School of Medicine, University of Mostar, 88000 Mostar, Bosnia and Herzegovina., Marijanović I; Clinic of Oncology, University Clinical Hospital Mostar, 88000 Mostar, Bosnia and Herzegovina., Kraljević M; Clinic of Oncology, University Clinical Hospital Mostar, 88000 Mostar, Bosnia and Herzegovina., Urlić M; Department of Cardiac Surgery, University Hospital Centre Zagreb, 10000 Zagreb, Croatia., Marić S; Odjel za Patološku Anatomiju i Citologiju, Kantonalna Bolnica Dr. Safet Mujić, 88000 Mostar, Bosnia and Herzegovina., Vukojević K; Laboratory of Morphology, Department of Histology and Embryology, School of Medicine, University of Mostar, 88000 Mostar, Bosnia and Herzegovina.; Faculty of Health Studies, University of Mostar, 88000 Mostar, Bosnia and Herzegovina.; Department of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia., Filipović N; Department of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia. |
| Abstrakt: |
Precision medicine is a developing trend in oncology, and it includes the prognosis and treatment of advanced-stage ccRCC. New predictive factors and therapeutic targets for this disease are steadily needed. The aim of this study was to explore the tumor expression of inversin as a potential prognostic factor and/or therapeutic target in ccRCC. We compared the expression of inversin between primary ccRCC and normal renal tissues by using immunohistochemistry and rtPCR in our cohort, and we also analyzed publicly available data from the TCGA-KIRC cohort. We found that the expression of inversin was significantly lower in primary tumor tissue, in comparison to solid normal tissue. Data from the KIRC study confirmed that a lower INVS expression level in ccRCC was significantly related with the overall and disease-specific survival, as well as with a shorter progression-free interval ( p < 0.05). Four out of ten inversin interactome partners were significantly related with the overall and disease-specific survival in ccRCC. A lower expression of ANKS6 was a negative survival predictor, while a higher expression of NPHP3 , DVL1 , or DVL3 was related with a lower survival. The expression of INVS and its interactome partners in ccRCC was correlated with the differentiation of the tumor and metastasis. The expression of INVS and its partners was also correlated with tumor leukocyte infiltration and the expression of immune checkpoint genes. The results of this study point to inversin and a distinguished group of its interactome partners as potential prognostic factors in ccRCC, with their predominant involvement in the modulation of the inflammatory infiltration of the tumor microenvironment and a strong relationship with the metastatic potential of the tumor. |
